Results 241 to 250 of about 1,620,802 (305)

Immunogenicity of adalimumab in patients with noninfectious uveitis based on therapeutic drug monitoring. [PDF]

J Transl Med
Han JW, Zhou Y, Guo J, Chen X.
europepmc   +1 more source

Percutaneous extraction using sponge spicules for disease diagnosis and therapeutic drug monitoring. [PDF]

Sci Rep
Li S, Zhang S, Jia M, Chen S, Zhang R, Liu Y, Yan G, Chen M.   +7 more
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, EarlyView.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source